M33 Growth I L.P. - Nov 18, 2025 Form 4 Insider Report for Oncology Institute, Inc. (TOI)

Role
Director
Signature
/s/ Gabriel Ling, Managing Member of M33 Growth I GP LLC, the general partner of M33 Growth I LP
Stock symbol
TOI
Transactions as of
Nov 18, 2025
Transactions value $
$0
Form type
4
Date filed
11/20/2025, 04:02 PM
Previous filing
Sep 5, 2025
SEC
View on sec.gov

Reporting Owners (3)

Name Relationship Address Signature Signature date CIK
M33 Growth I L.P. Director 888 BOYLSTON STREET, SUITE 500, BOSTON /s/ Gabriel Ling, Managing Member of M33 Growth I GP LLC, the general partner of M33 Growth I LP 2025-11-20 0001718621
M33 Growth I GP LLC Director 888 BOYLSTON STREET,, SUITE 500, BOSTON /s/ Gabriel Ling, Managing Member of M33 Growth I GP LLC 2025-11-20 0001894303
TOI M, LLC Director 888 BOYLSTON STREET,, SUITE 500, BOSTON /s/ Gabriel Ling, Managing Member of TOI M, LLC 2025-11-20 0001892968

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TOI Common Stock Other -591K -100% 0 Nov 18, 2025 See Footnote F1, F2
transaction TOI Common Stock Other +11.8K +0.15% 7.94M Nov 18, 2025 Direct F1, F3
transaction TOI Common Stock Other -2.5M -31.47% 5.44M Nov 18, 2025 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On November 18, 2025, TOI M, LLC made a distribution in-kind of 590,892 shares of the Issuer's common stock to its members, including 11,818 shares distributed to M33 Growth I L.P. ("M33 LP"). Also on November 18, 2025, M33 LP made a distribution-in-kind of 2,500,000 shares of the Issuer's common stock to its limited partners.
F2 These securities were held by TOI M, LLC.
F3 M33 Growth I GP LLC is the general partner of M33 LP and may be deemed to beneficially own the shares held by M33 LP but disclaims beneficial ownership of these shares except to the extent of its pecuniary interest therein.